You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • OP0185 Significant Clinical Improvement and Reduction of Severe Flares Following Administration of an IL-6 Monoclonal Antibody in Systemic Lupus Erythematosus (SLE) Subjects with High Disease Activity

Citation Tools

Article menu
Download PDFPDF
Oral Presentations
Abstract session: SLE and Sjögren's: new treatment options
OP0185 Significant Clinical Improvement and Reduction of Severe Flares Following Administration of an IL-6 Monoclonal Antibody in Systemic Lupus Erythematosus (SLE) Subjects with High Disease Activity

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Smolen J, Popa S, Szombati I, et al
OP0185 Significant Clinical Improvement and Reduction of Severe Flares Following Administration of an IL-6 Monoclonal Antibody in Systemic Lupus Erythematosus (SLE) Subjects with High Disease Activity
Annals of the Rheumatic Diseases 2015;74:141-142.